Faes Farma S.A./€FAE
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Faes Farma S.A.
Faes Farma S.A. is a pharmaceutical company engaged in the research, production, and marketing of pharmaceutical products. Headquartered in Leioa, Spain, the company operates primarily in the pharmaceuticals and animal health sectors. Key products include prescription medications for human health, over-the-counter medicines, and nutritional supplements, as well as products for veterinary use. Founded in 1933, Faes Farma has expanded its operations to various international markets, particularly in Europe and Latin America. Its competitive strength lies in its robust R&D capabilities and a well-established distribution network.
Ticker
€FAE
Sector
Primary listing
BME
Employees
2,611
Headquarters
Website
Faes Farma S.A. Metrics
BasicAdvanced
€1.4bn
16.89
€0.27
0.34
€0.10
2.29%
Price and volume
Market cap
€1.4bn
Beta
0.34
52-week high
€5.84
52-week low
€4.13
Average daily volume
115k
Dividend rate
€0.10
Financial strength
Current ratio
2.634
Quick ratio
1.663
Long term debt to equity
49.447
Total debt to equity
57.946
Dividend payout ratio (TTM)
66.19%
Interest coverage (TTM)
10.05%
Profitability
EBITDA (TTM)
125.74
Gross margin (TTM)
65.17%
Net profit margin (TTM)
11.84%
Operating margin (TTM)
13.81%
Effective tax rate (TTM)
6.77%
Revenue per employee (TTM)
€270,000
Management effectiveness
Return on assets (TTM)
5.03%
Return on equity (TTM)
11.22%
Valuation
Price to earnings (TTM)
16.894
Price to revenue (TTM)
1.983
Price to book
1.82
Price to tangible book (TTM)
5.38
Price to free cash flow (TTM)
25.719
Free cash flow yield (TTM)
3.89%
Free cash flow per share (TTM)
0.176
Dividend yield (TTM)
2.29%
Growth
Revenue change (TTM)
30.76%
Earnings per share change (TTM)
-20.43%
3-year revenue growth (CAGR)
14.91%
10-year revenue growth (CAGR)
12.34%
3-year earnings per share growth (CAGR)
-2.62%
10-year earnings per share growth (CAGR)
7.58%
3-year dividend per share growth (CAGR)
-17.86%
10-year dividend per share growth (CAGR)
18.09%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.